Semaglutide 20mg/3mL

GLP-1 Receptor Agonist. Ultra-High Dose for Extended Research.

Semaglutide is a GLP-1 receptor agonist with a proven research profile for weight management and metabolic health. This ultra-high dose 20mg/3mL vial is designed for extended, serious research protocols requiring maximum potency and sustained GLP-1 receptor activation.

• GLP-1 receptor agonist for appetite regulation
• Supports significant and sustained weight reduction
• Improves insulin sensitivity and blood sugar regulation
• Slows gastric emptying to promote satiety
• 20mg/3mL vial — ultra-high dose for extended protocols
• Made in the USA in a licensed compounding pharmacy